1. Home
  2. IBRX vs AKR Comparison

IBRX vs AKR Comparison

Compare IBRX & AKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IBRX
  • AKR
  • Stock Information
  • Founded
  • IBRX 2014
  • AKR 1993
  • Country
  • IBRX United States
  • AKR United States
  • Employees
  • IBRX N/A
  • AKR N/A
  • Industry
  • IBRX Biotechnology: Biological Products (No Diagnostic Substances)
  • AKR Real Estate Investment Trusts
  • Sector
  • IBRX Health Care
  • AKR Real Estate
  • Exchange
  • IBRX Nasdaq
  • AKR Nasdaq
  • Market Cap
  • IBRX 2.3B
  • AKR 2.6B
  • IPO Year
  • IBRX N/A
  • AKR 1993
  • Fundamental
  • Price
  • IBRX $2.31
  • AKR $20.06
  • Analyst Decision
  • IBRX Strong Buy
  • AKR Strong Buy
  • Analyst Count
  • IBRX 5
  • AKR 2
  • Target Price
  • IBRX $10.20
  • AKR $25.00
  • AVG Volume (30 Days)
  • IBRX 9.0M
  • AKR 1.5M
  • Earning Date
  • IBRX 08-05-2025
  • AKR 10-27-2025
  • Dividend Yield
  • IBRX N/A
  • AKR 4.01%
  • EPS Growth
  • IBRX N/A
  • AKR 1674.20
  • EPS
  • IBRX N/A
  • AKR 0.16
  • Revenue
  • IBRX $56,600,000.00
  • AKR $391,852,000.00
  • Revenue This Year
  • IBRX $629.94
  • AKR N/A
  • Revenue Next Year
  • IBRX $109.91
  • AKR $10.62
  • P/E Ratio
  • IBRX N/A
  • AKR $126.06
  • Revenue Growth
  • IBRX 4227.22
  • AKR 13.78
  • 52 Week Low
  • IBRX $1.83
  • AKR $16.98
  • 52 Week High
  • IBRX $7.48
  • AKR $26.29
  • Technical
  • Relative Strength Index (RSI)
  • IBRX 45.80
  • AKR 62.63
  • Support Level
  • IBRX $2.17
  • AKR $19.59
  • Resistance Level
  • IBRX $2.43
  • AKR $20.25
  • Average True Range (ATR)
  • IBRX 0.15
  • AKR 0.42
  • MACD
  • IBRX 0.00
  • AKR 0.10
  • Stochastic Oscillator
  • IBRX 27.92
  • AKR 90.76

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

About AKR Acadia Realty Trust

Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company operates through three segments: Core Portfolio segment consists primarily of high-quality retail properties located primarily in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon; Investment Management segment holds primarily retail real estate in which the company co-invests with high-quality institutional investors; and Structured Financing segment consists of earnings and expenses related to notes and mortgages receivable Fees earned by the company as the general partner or managing member through Investment Management.

Share on Social Networks: